HCW Biologics is a company that is focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. These diseases include cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, and autoimmune diseases. Q1 2022 hedge fund letters, conferences and more The insider purchase and previous accumulation trends have driven the Fintel officer accumulation score higher to 96.75. This places HCWB in 2nd place out of 11,702 analyzed companies. In addition to this score, has an insi…
